Evidence
Folia Neuropathol. 2023;61(2):111-120. doi: 10.5114/fn.2023.128776.
ABSTRACT
Transactivation (TAR) DNA binding protein 43 kDa (TDP-43) inclusions frequently occur as a comorbid pathology in several neurodegenerative disorders, including Alzheimer’s disease, Huntington’s disease, Lewy body disease, and progressive supranuclear palsy, and may appear in association with nondegenerative neurological etiology, for example neoplastic, paraneoplastic, traumatic, or infectious. Relationships between various pathological proteins and mechanisms associated with TDP-43-induced neurodegeneration are still not fully understood. Thus, overlap of distinct neuropathological mechanisms frequently leads to greater brain atrophy and a more severe clinical course, suggesting the importance of co-pathologies in ante-mortem diagnosing and treatment. The present review aims to discuss the incidence, morphology, and role of TDP-43 pathology in the context of other dominant, hallmark pathologies, referred to as secondary TDP-43 proteinopathies. The previous part (Part 1) focused on common neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, and Lewy body disease, while the present part (Part 2) discusses TDP-43 pathology in rare neurodegenerative diseases and neurological diseases with nondegenerative etiology.
PMID:37587885 | DOI:10.5114/fn.2023.128776
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
🌐 90 Days
VR Related Evidence Matrix
- Production and characterization of novel monoclonal antibodies against pathological human TDP-43 proteins
- Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models
- Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy
- Anterior insula is more vulnerable than posterior insula to TDP-43 pathology in common dementias and ALS
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis
- Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Ageing-Related Neurodegeneration and Cognitive Decline
- Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- Advancing amyotrophic lateral sclerosis disease diagnosis: A lab-on-chip electrochemical immunosensor for ultra-sensitive TDP-43 protein detection and monitoring in serum patients'
- Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Lateral geniculate body is spared of tau pathology in Pick disease
- Single episode of moderate to severe traumatic brain injury leads to chronic neurological deficits and Alzheimer's-like pathological dementia
- Single episode of moderate to severe traumatic brain injury leads to chronic neurological deficits and Alzheimer's-like pathological dementia
- Single episode of moderate to severe traumatic brain injury leads to chronic neurological deficits and Alzheimer's-like pathological dementia
- Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- The complement system in neurodegenerative diseases
- Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
- Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
- Innate immune activation in neurodegenerative diseases
- Association between hypothalamic Alzheimer's disease pathology and body mass index: The Hisayama study
- A current view of mitochondria damage and the diversity of lipopigment inclusions in neuronal ceroid lipofuscinose type 2 from rectal biopsy
- The Body, the Brain, the Environment, and Parkinson's Disease
- Progress in Primary Progressive Aphasia: A Review
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
- The vascular contribution of apolipoprotein E to Alzheimer's disease
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Depletion of Mettl3 in cholinergic neurons causes adult-onset neuromuscular degeneration
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- New knowledge on anti-IgLON5 disease
- Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy
- Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy
- Genomic stress and impaired DNA repair in Alzheimer disease
- Investigating neuropathological changes and underlying neurobiological mechanisms in the early stages of primary blast-induced traumatic brain injury: Insights from a rat model
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Genetic-based patient stratification in Alzheimer's disease
- Slow disease progression and characteristic TDP-43 inclusions in a patient with familial amyotrophic lateral sclerosis carrying a TARDBP G357S variant
- Neuropathologic changes at age 90+ related to sleep duration 19 to 40 years earlier: The 90+ Study
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change
- Mutations in human prion-like domains: pathogenic but not always amyloidogenic
- Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice
- Brain Banking in Dementia Studies
- When prion disease Isn't suspected: prion disease as the cause of terminal decline in chronic mixed dementia
Evidence Blueprint
Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
🌐 365 Days
VR Related Evidence Matrix
- Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis
- Production and characterization of novel monoclonal antibodies against pathological human TDP-43 proteins
- Comprehensive mapping of mutations in TDP-43 and α-Synuclein that affect stability and binding
- Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders
- Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline
- A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
- Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells
- Single Versus Repetitive Traumatic Brain Injury: Current Knowledge on the Chronic Outcomes, Neuropathology and the Role of TDP-43 Proteinopathy
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD
- Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS
- TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy
- A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
- TDP-43 chronic deficiency leads to dysregulation of transposable elements and gene expression by affecting R-loop and 5hmC crosstalk
- Atypical TDP-43 proteinopathy clinically presenting with progressive nonfluent aphasia: A case report
- Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
- Anterior insula is more vulnerable than posterior insula to TDP-43 pathology in common dementias and ALS
- Pathology of neurodegenerative disease for the general neurologist
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome
- Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum
- Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala
- Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia
- Polypathologic associations with grey matter atrophy in neurodegenerative disease
- TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations
- Loss of TDP-43 mediates severe neurotoxicity by suppressing PJA1 gene transcription in the monkey brain
- Distinct Patterns of Hippocampal Pathology in Alzheimer's Disease with TDP-43
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- Psychotic Symptoms in Frontotemporal Dementia with TDP-43 tend to be associated with subtype B pathology
- Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample
- A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
- Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis
- The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis
- Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice
- Neuroanatomical and cellular degeneration associated with a social disorder characterized by new ritualistic belief systems in a TDP-C patient vs. a Pick patient
- Disrupting pathologic phase transitions in neurodegeneration
- Retrospective neuropathological diagnosis of TDP-43 proteinopathies: Factors affecting immunoreactivity of phosphorylated TDP-43 in fixed post-mortem brain tissue
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Ageing-Related Neurodegeneration and Cognitive Decline
- Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
- Relative contributions of mixed pathologies to cognitive and functional symptoms in brain donors exposed to repetitive head impacts
- Neuropathology of Alzheimer's Disease
- TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia
- Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases